Literature DB >> 12364515

Anticonvulsant actions of gap junctional blockers in an in vitro seizure model.

Shokrollah S Jahromi1, Kirsten Wentlandt, Sanaz Piran, Peter L Carlen.   

Abstract

Gap junctions (gjs) are increasingly recognized as playing a significant role in seizures. We demonstrate that different types of gap junctional blocking agents reduce the duration of evoked seizure-like primary afterdischarges (PADs) in the rat in vitro CA1 hippocampal pyramidal region, following repetitive tetanization of the Schaffer collaterals. Intracellular acidosis, which is known to block gap junctional communication, decreased the PADs, whereas alkalinization increased the PADs. Cellular excitability was not significantly depressed as determined by input/output relations recorded before and during perfusion of the gj blockers blockers carbenoxolone and sodium propionate. There was a small decrease following 1-octanol perfusion and a large decrease following NH(4)Cl application. Carbenoxolone diminished PAD duration, but increased neuronal excitability in whole-cell recordings. After robust PADs were established, the expression of several gj proteins including connexins (Cxs) 26, 32, 36, and 43, as measured by Western blotting, was unchanged, although the level of nonphosphorylated Cx43 was decreased. Our data support the concept that blocking gap junctional communication is an anticonvulsant mechanism.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12364515     DOI: 10.1152/jn.2002.88.4.1893

Source DB:  PubMed          Journal:  J Neurophysiol        ISSN: 0022-3077            Impact factor:   2.714


  33 in total

1.  Sequence and phylogenetic analyses of 4 TMS junctional proteins of animals: connexins, innexins, claudins and occludins.

Authors:  V B Hua; A B Chang; J H Tchieu; N M Kumar; P A Nielsen; M H Saier
Journal:  J Membr Biol       Date:  2003-07-01       Impact factor: 1.843

2.  Closing the gap: electrotonic junctions in seizure control.

Authors:  Carl E Stafstrom
Journal:  Epilepsy Curr       Date:  2004 Sep-Oct       Impact factor: 7.500

3.  Propagation of postsynaptic currents and potentials via gap junctions in GABAergic networks of the rat hippocampus.

Authors:  Veronika Zsiros; Ildiko Aradi; Gianmaria Maccaferri
Journal:  J Physiol       Date:  2006-11-16       Impact factor: 5.182

4.  Scn2a sodium channel mutation results in hyperexcitability in the hippocampus in vitro.

Authors:  Kara Buehrer Kile; Nan Tian; Dominique M Durand
Journal:  Epilepsia       Date:  2007-11-21       Impact factor: 5.864

5.  Gq-activated fibroblasts induce cardiomyocyte action potential prolongation and automaticity in a three-dimensional microtissue environment.

Authors:  C M Kofron; T Y Kim; M E King; A Xie; F Feng; E Park; Z Qu; B-R Choi; U Mende
Journal:  Am J Physiol Heart Circ Physiol       Date:  2017-07-14       Impact factor: 4.733

Review 6.  The role of gap junction channels during physiologic and pathologic conditions of the human central nervous system.

Authors:  Eliseo A Eugenin; Daniel Basilio; Juan C Sáez; Juan A Orellana; Cedric S Raine; Feliksas Bukauskas; Michael V L Bennett; Joan W Berman
Journal:  J Neuroimmune Pharmacol       Date:  2012-03-23       Impact factor: 4.147

Review 7.  Molecular targets for antiepileptic drug development.

Authors:  Brian S Meldrum; Michael A Rogawski
Journal:  Neurotherapeutics       Date:  2007-01       Impact factor: 7.620

8.  Transition to seizures in the isolated immature mouse hippocampus: a switch from dominant phasic inhibition to dominant phasic excitation.

Authors:  M Derchansky; S S Jahromi; M Mamani; D S Shin; A Sik; P L Carlen
Journal:  J Physiol       Date:  2007-11-08       Impact factor: 5.182

9.  Impaired astrocytic gap junction coupling and potassium buffering in a mouse model of tuberous sclerosis complex.

Authors:  Lin Xu; Ling-Hui Zeng; Michael Wong
Journal:  Neurobiol Dis       Date:  2009-05       Impact factor: 5.996

10.  Direct actions of carbenoxolone on synaptic transmission and neuronal membrane properties.

Authors:  Kenneth R Tovar; Brady J Maher; Gary L Westbrook
Journal:  J Neurophysiol       Date:  2009-06-17       Impact factor: 2.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.